These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

206 related items for PubMed ID: 18307460

  • 1. Beneficial effects of rosiglitazone on novel cardiovascular risk factors in patients with Type 2 diabetes mellitus.
    Kadoglou NP, Iliadis F, Angelopoulou N, Perrea D, Liapis CD, Alevizos M.
    Diabet Med; 2008 Mar; 25(3):333-40. PubMed ID: 18307460
    [Abstract] [Full Text] [Related]

  • 2. The anti-inflammatory effects of exercise training in patients with type 2 diabetes mellitus.
    Kadoglou NP, Iliadis F, Angelopoulou N, Perrea D, Ampatzidis G, Liapis CD, Alevizos M.
    Eur J Cardiovasc Prev Rehabil; 2007 Dec; 14(6):837-43. PubMed ID: 18043308
    [Abstract] [Full Text] [Related]

  • 3. Effects of rosiglitazone and metformin treatment on apelin, visfatin, and ghrelin levels in patients with type 2 diabetes mellitus.
    Kadoglou NP, Tsanikidis H, Kapelouzou A, Vrabas I, Vitta I, Karayannacos PE, Liapis CD, Sailer N.
    Metabolism; 2010 Mar; 59(3):373-9. PubMed ID: 19815243
    [Abstract] [Full Text] [Related]

  • 4. Effects of pioglitazone and metformin on plasma adiponectin in newly detected type 2 diabetes mellitus.
    Sharma PK, Bhansali A, Sialy R, Malhotra S, Pandhi P.
    Clin Endocrinol (Oxf); 2006 Dec; 65(6):722-8. PubMed ID: 17121522
    [Abstract] [Full Text] [Related]

  • 5. Rosiglitazone and pioglitazone similarly improve insulin sensitivity and secretion, glucose tolerance and adipocytokines in type 2 diabetic patients.
    Miyazaki Y, DeFronzo RA.
    Diabetes Obes Metab; 2008 Dec; 10(12):1204-11. PubMed ID: 18476983
    [Abstract] [Full Text] [Related]

  • 6. Exercise ameliorates serum MMP-9 and TIMP-2 levels in patients with type 2 diabetes.
    Kadoglou NP, Vrabas IS, Sailer N, Kapelouzou A, Fotiadis G, Noussios G, Karayannacos PE, Angelopoulou N.
    Diabetes Metab; 2010 Apr; 36(2):144-51. PubMed ID: 20149706
    [Abstract] [Full Text] [Related]

  • 7. Effects of rosiglitazone/metformin fixed-dose combination therapy and metformin monotherapy on serum vaspin, adiponectin and IL-6 levels in drug-naïve patients with type 2 diabetes.
    Kadoglou NP, Kapelouzou A, Tsanikidis H, Vitta I, Liapis CD, Sailer N.
    Exp Clin Endocrinol Diabetes; 2011 Feb; 119(2):63-8. PubMed ID: 21031343
    [Abstract] [Full Text] [Related]

  • 8. Effects of rosiglitazone alone and in combination with atorvastatin on nontraditional markers of cardiovascular disease in patients with type 2 diabetes mellitus.
    Chu CS, Lee KT, Lee MY, Su HM, Voon WC, Sheu SH, Lai WT.
    Am J Cardiol; 2006 Mar 01; 97(5):646-50. PubMed ID: 16490430
    [Abstract] [Full Text] [Related]

  • 9. Rosiglitazone improves insulin sensitivity in nonobese subjects with impaired glucose tolerance: the role of adiponectin and C-reactive protein.
    Hung YJ, Lin SH, Pei D, Kuo SW, Hsieh CH, He CT, Hsing Lee C, Fan SC, Sheu WH.
    Metabolism; 2006 Apr 01; 55(4):439-44. PubMed ID: 16546473
    [Abstract] [Full Text] [Related]

  • 10. Effects of rosiglitazone and metformin on inflammatory markers and adipokines: decrease in interleukin-18 is an independent factor for the improvement of homeostasis model assessment-beta in type 2 diabetes mellitus.
    Kim HJ, Kang ES, Kim DJ, Kim SH, Ahn CW, Cha BS, Nam M, Chung CH, Lee KW, Nam CM, Lee HC.
    Clin Endocrinol (Oxf); 2007 Feb 01; 66(2):282-9. PubMed ID: 17224000
    [Abstract] [Full Text] [Related]

  • 11. A randomized trial of the effects of rosiglitazone and metformin on inflammation and subclinical atherosclerosis in patients with type 2 diabetes.
    Stocker DJ, Taylor AJ, Langley RW, Jezior MR, Vigersky RA.
    Am Heart J; 2007 Mar 01; 153(3):445.e1-6. PubMed ID: 17307426
    [Abstract] [Full Text] [Related]

  • 12. Pharmacodynamic effects of rosiglitazone in nondiabetic patients with metabolic syndrome.
    Aquilante CL, Kosmiski LA, Zineh I, Rome LC, Knutsen SD.
    Pharmacotherapy; 2010 Mar 01; 30(3):236-47. PubMed ID: 20180607
    [Abstract] [Full Text] [Related]

  • 13. Effect of long-term treatment with rosiglitazone on arterial elasticity and metabolic parameters in patients with Type 2 diabetes mellitus: a 2-year follow-up study.
    Shargorodsky M, Michaelova K, Boaz M, Gavish D, Zimlichman R.
    Diabet Med; 2007 Nov 01; 24(11):1254-60. PubMed ID: 17725634
    [Abstract] [Full Text] [Related]

  • 14. Cardiorespiratory capacity is associated with favourable cardiovascular risk profile in patients with Type 2 diabetes.
    Kadoglou NP, Iliadis F, Angelopoulou N, Sailer N, Fotiadis G, Voliotis K, Vitta I, Liapis CD, Alevizos M.
    J Diabetes Complications; 2009 Nov 01; 23(3):160-6. PubMed ID: 18413173
    [Abstract] [Full Text] [Related]

  • 15. Effects of rosiglitazone and aspirin on experimental model of induced type 2 diabetes in rats: focus on insulin resistance and inflammatory markers.
    Abdin AA, Baalash AA, Hamooda HE.
    J Diabetes Complications; 2010 Nov 01; 24(3):168-78. PubMed ID: 19328014
    [Abstract] [Full Text] [Related]

  • 16. Sibutramine effect on metabolic control of obese patients with type 2 diabetes mellitus treated with pioglitazone.
    Derosa G, D'Angelo A, Salvadeo SA, Ferrari I, Gravina A, Fogari E, Maffioli P, Cicero AF.
    Metabolism; 2008 Nov 01; 57(11):1552-7. PubMed ID: 18940393
    [Abstract] [Full Text] [Related]

  • 17. The effect of rosiglitazone on novel atherosclerotic risk factors in patients with type 2 diabetes mellitus and hypertension. An open-label observational study.
    Sarafidis PA, Lasaridis AN, Nilsson PM, Mouslech TF, Hitoglou-Makedou AD, Stafylas PC, Kazakos KA, Yovos JG, Tourkantonis AA.
    Metabolism; 2005 Sep 01; 54(9):1236-42. PubMed ID: 16125536
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Comparison of the effects of pioglitazone and metformin on insulin resistance and hormonal markers in patients with impaired glucose tolerance and early diabetes.
    Eguchi K, Tomizawa H, Ishikawa J, Hoshide S, Numao T, Fukuda T, Shimada K, Kario K.
    Hypertens Res; 2007 Jan 01; 30(1):23-30. PubMed ID: 17460368
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.